These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 26795201)
1. Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis. Bao J; Wang XJ; Mao ZF Med Sci Monit; 2016 Jan; 22():234-43. PubMed ID: 26795201 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the rs2075650 polymorphism and risk of Alzheimer disease. He Y; Li C; Yang Y; Li Y; Wang Y; Yang H; Jin T; Chen S Aging Clin Exp Res; 2016 Oct; 28(5):805-11. PubMed ID: 26572157 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population. Omoumi A; Fok A; Greenwood T; Sadovnick AD; Feldman HH; Hsiung GY Neurobiol Aging; 2014 Apr; 35(4):936.e5-12. PubMed ID: 24176626 [TBL] [Abstract][Full Text] [Related]
4. The TOMM40 gene rs2075650 polymorphism contributes to Alzheimer's disease in Caucasian, and Asian populations. Huang H; Zhao J; Xu B; Ma X; Dai Q; Li T; Xue F; Chen B Neurosci Lett; 2016 Aug; 628():142-6. PubMed ID: 27328316 [TBL] [Abstract][Full Text] [Related]
5. Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a Northern Han Chinese population. Ma XY; Yu JT; Wang W; Wang HF; Liu QY; Zhang W; Tan L Neuromolecular Med; 2013 Jun; 15(2):279-87. PubMed ID: 23288655 [TBL] [Abstract][Full Text] [Related]
7. Independent associations of TOMM40 and APOE variants with body mass index. Kulminski AM; Loika Y; Culminskaya I; Huang J; Arbeev KG; Bagley O; Feitosa MF; Zmuda JM; Christensen K; Yashin AI; Aging Cell; 2019 Feb; 18(1):e12869. PubMed ID: 30462377 [TBL] [Abstract][Full Text] [Related]
8. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele. Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488 [TBL] [Abstract][Full Text] [Related]
9. CD33 rs3865444 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Chinese, European, and North American Populations. Li X; Shen N; Zhang S; Liu J; Jiang Q; Liao M; Feng R; Zhang L; Wang G; Ma G; Zhou H; Chen Z; Jiang Y; Zhao B; Li K; Liu G Mol Neurobiol; 2015 Aug; 52(1):414-21. PubMed ID: 25186233 [TBL] [Abstract][Full Text] [Related]
10. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease. Dos Santos LR; Pimassoni LHS; Sena GGS; Camporez D; Belcavello L; Trancozo M; Morelato RL; Errera FIV; Bueno MRP; de Paula F J Mol Neurosci; 2017 Jun; 62(2):215-221. PubMed ID: 28477215 [TBL] [Abstract][Full Text] [Related]
11. Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations. Mao YF; Guo ZY; Pu JL; Chen YX; Zhang BR Neurosci Lett; 2015 Nov; 609():235-9. PubMed ID: 26455864 [TBL] [Abstract][Full Text] [Related]
12. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility. Raj T; Ryan KJ; Replogle JM; Chibnik LB; Rosenkrantz L; Tang A; Rothamel K; Stranger BE; Bennett DA; Evans DA; De Jager PL; Bradshaw EM Hum Mol Genet; 2014 May; 23(10):2729-36. PubMed ID: 24381305 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Jun G; Vardarajan BN; Buros J; Yu CE; Hawk MV; Dombroski BA; Crane PK; Larson EB; ; Mayeux R; Haines JL; Lunetta KL; Pericak-Vance MA; Schellenberg GD; Farrer LA Arch Neurol; 2012 Oct; 69(10):1270-9. PubMed ID: 22869155 [TBL] [Abstract][Full Text] [Related]
14. TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients. Bagnoli S; Piaceri I; Tedde A; Bessi V; Bracco L; Sorbi S; Nacmias B Neurol Sci; 2013 Jun; 34(6):995-8. PubMed ID: 23546992 [TBL] [Abstract][Full Text] [Related]
15. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing. Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390 [TBL] [Abstract][Full Text] [Related]
16. TOMM40 rs2075650 polymorphism shows no association with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy in a Chinese population. Guo J; Li H; Zhang C; Sun Y; Deng X; Bai Y; Li S; Zhao M; Miao H; Yu W; Wang B; Huang L; Li X Mol Vis; 2013; 19():2050-7. PubMed ID: 24146538 [TBL] [Abstract][Full Text] [Related]
17. Alzheimer's diseases in America, Europe, and Asian regions: a global genetic variation. Hossain R; Noonong K; Nuinoon M; Lao-On U; Norris CM; Sompol P; Rahman MA; Majima HJ; Tangpong J PeerJ; 2024; 12():e17339. PubMed ID: 38756443 [TBL] [Abstract][Full Text] [Related]
18. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population. Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468 [TBL] [Abstract][Full Text] [Related]
19. A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases. Soyal SM; Kwik M; Kalev O; Lenz S; Zara G; Strasser P; Patsch W; Weis S Mol Genet Genomic Med; 2020 Aug; 8(8):e1317. PubMed ID: 32472747 [TBL] [Abstract][Full Text] [Related]
20. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. Reitz C; Jun G; Naj A; Rajbhandary R; Vardarajan BN; Wang LS; Valladares O; Lin CF; Larson EB; Graff-Radford NR; Evans D; De Jager PL; Crane PK; Buxbaum JD; Murrell JR; Raj T; Ertekin-Taner N; Logue M; Baldwin CT; Green RC; Barnes LL; Cantwell LB; Fallin MD; Go RC; Griffith P; Obisesan TO; Manly JJ; Lunetta KL; Kamboh MI; Lopez OL; Bennett DA; Hendrie H; Hall KS; Goate AM; Byrd GS; Kukull WA; Foroud TM; Haines JL; Farrer LA; Pericak-Vance MA; Schellenberg GD; Mayeux R; JAMA; 2013 Apr; 309(14):1483-92. PubMed ID: 23571587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]